"10.1371_journal.pone.0132745","plos one","2015-07-20T00:00:00Z","Ahmad A Tarhini; Yan Lin; Haris Zahoor; Yongli Shuai; Lisa H Butterfield; Steven Ringquist; Helen Gogas; Cindy Sander; Sandra Lee; Sanjiv S Agarwala; John M Kirwood","University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; University of Pittsburgh Cancer Institute Biostatistics Facility, Pittsburgh, Pennsylvania, United States of America; Hellenic Cooperative Oncology Group, Athens, Greece; Dana Farber Cancer Institute, Boston, Massachusetts, United States of America; St. Luke's Cancer Center, Bethlehem, Pennsylvania, United States of America; Temple University, Philadelphia, Pennsylvania, United States of America","Conceived and designed the experiments: AT JMK YL. Performed the experiments: AT CS LHB SR HZ. Analyzed the data: AT YL YS. Contributed reagents/materials/analysis tools: SR SL HG SSA. Wrote the paper: AT YL HZ YS LHB HG CS SL SSA JMK.","The authors have read the journal's policy and the authors of this manuscript have the following competing interests: This study was funded in part by DiaSorin Inc and Merck. Ahmad Tarhini – Research grant support from Merck, Consultant role (advisory board participation) with Merck. Helen Gogas – Consultant role in Roche, GSK, BMS, Amgen, MSD and Novartis. These are not related with the biomarker manuscript. John Kirkwood – Consulting role with BMS, Merck, GSK, Celgene, Vical, and Ziopharm. Grant funding from Promethius. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2015","07","Ahmad A Tarhini","AAT",11,TRUE,3,5,3,10,TRUE,TRUE,FALSE,0,NA,FALSE
